Skip to main content
. Author manuscript; available in PMC: 2008 Aug 20.
Published in final edited form as: J Cardiovasc Electrophysiol. 2006 Nov;17(11):1230–1238. doi: 10.1111/j.1540-8167.2006.00592.x

Table 1.

Patients' characteristics. Values are numbers of patients (n and % of total) with selected clinical characteristics, except for age and heart rate (mean±SE). ACE, angiotensin converting enzyme; ASD, atrial septal defect; AVR, aortic valve replacement; bpm, beats per min; CABG, coronary artery bypass graft surgery; CCB, calcium channel blocker; f, female; LVSD, left ventricular systolic dysfunction; m, male; MI, myocardial infarction; MVR, mitral valve replacement; post-CS AF, post-cardiac surgery atrial fibrillation; VSD, ventricular septal defect.

Post-CS AF no Post-CS AF yes
n % n %
Patient details Total (m/f) 159 (124/35) (78/22) 53 (33/20) (62/38)
Age (years) 61.2±0.8 - 66.5±1.3 -
Heart rate (bpm) 63.3±1.1 - 62.3±2.1 -
Drug treatments Lipid lowering 134 84 43 81
Beta-blocker 109 69 32 60
Nitrate 78 49 23 43
ACE inhibitor 82 52 21 40
CCB 62 39 21 40
Diuretic 43 27 16 30
Operation type CABG 135 85 43 81
AVR 9 6 6 11
CABG+AVR 10 6 3 6
MVR 2 1 1 2
CABG+MVR 1 1 0 0
ASD 1 1 0 0
VSD 1 1 0 0
LVSD Normal 98 62 35 66
Mild/moderate 56 35 14 26
Severe 5 3 3 6
Disease Angina 145 91 48 91
Hyperlipidaemia 124 78 43 81
Hypertension 86 54 31 58
Previous MI 66 42 24 45
Diabetes 19 12 6 11